Today: 9 June 2026
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end
31 December 2025
1 min read

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

NEW YORK, December 31, 2025, 05:02 ET — Premarket

Aimei Health Technology Co., Ltd shares rose 38% to $114 in premarket trading on Wednesday, extending Tuesday’s outsized move in the Nasdaq-listed blank-check company. The stock ended the prior session up 89% at $82.58 after trading in a wide range.

The spike matters because Aimei’s share count shrank sharply after recent redemptions, a setup that can amplify price swings when even modest buying hits a thin market. In a Dec. 2 filing, the company said shareholders redeemed 3,942,661 public shares for about $44.8 million, and that it would have about 2.18 million shares outstanding after the redemptions, with roughly $0.7 million left in its trust account.

The stock is also trading against a SPAC deadline. In an 8-K filed in early December, Aimei said it deposited $34,330.96 into its trust account to extend the period to complete an initial business combination by one month, moving its termination date to Jan. 6, 2026, and funded the deposit with a promissory note tied to a planned business combination with United Hydrogen Group Inc.

Tuesday’s rally came on about 918,000 shares traded, roughly four times the 65-day average, according to market data tracked by Finviz.

Aimei is a SPAC — a “blank-check” company that raises cash and looks for a private company to merge with — and that structure can create sharp, news-light moves when the pool of tradable shares gets small.

Traders call that a “low float,” meaning a limited number of shares are available to change hands. When supply is tight, price can gap higher quickly, and just as quickly reverse if early buyers take profits.

Premarket trading often exaggerates those swings because liquidity is thinner before the opening bell and a few prints can move the quote.

Investors will be watching whether the stock holds its early gains once regular trading begins and whether volatility triggers exchange pauses.

Technically, traders tend to key off round-number levels in fast movers. A sustained hold above $100 can keep momentum players involved, while a drop back toward the prior close would test how much demand is real versus purely tactical.

Stock Market Today

  • Jim Cramer's Top 10 Market Watch Points for June 9
    June 9, 2026, 9:57 AM EDT. Jim Cramer's top 10 things to watch on June 9 include U.S. stocks rebounding after a selloff, supported by lower oil prices and bond yields. The SpaceX IPO is heavily oversubscribed, expected to start trading Friday, while OpenAI filed confidentially for its IPO with a potential trillion-dollar valuation. Anthropic secured a $35 billion debt deal to fund its AI growth. TD Cowen raised its Alphabet price target to $475 amid margin optimism, despite dilution concerns. Amazon issued a $10 billion Canadian dollar bond, the largest in that currency. China plans to invest $295 billion in AI data centers over five years. Micron is expected to beat earnings guidance, while Apple shares face pressure despite AI enhancements. GSK's $10.6 billion acquisition of Nuvalent lifts shares, highlighting moves in the healthcare sector.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Previous Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking
Next Story

Premium Bonds January 2026 draw date is set — here’s when NS&I results drop and why savers are rethinking

Go toTop